CuraeLase, Sister Company to CuraLase Global, Has FDA Medical Device Clearance
MYRTLE BEACH, S.C., June 4, 2012 /PRNewswire-iReach/ — CuraLase Global, Inc., a sister corporation to CuraeLase, Inc. (medical device manufacturer), announces plans to expand its footprint. Since receiving its FDA clearance in December 2005, the CuraeLase 1000 has proven efficacy and safety in over 60,000 treatments. CuraeLase, Inc. has submitted product reports and implemented documentation and procedures to ensure continued compliance with current FDA regulations.
CuraLase Global, Inc. is on a fast track of expansion. Having recently opened in Houston, Texas, CuraLase Global, Inc. plans to open within 60 days in Melbourne, Florida, and six other locations within twelve months.
It is internationally known for its ability to relieve pain associated with sciatica, fibromyalgia, arthritic joints and knees, and neurological conditions, such as trigeminal neuralgia, chronic regional pain syndrome (CRPS) and peripheral neuropathy.
Patients have flown from all over the United States and 10 other countries to receive CuraLase therapy. No one else offers lasting relief for these chronic conditions.
For more information, go to www.curalase.com.
Media Contact: Franchise Department, CuraLase Global, 843-294-5273, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE CuraLase Global